Maximize your business potential in growing OTC market with actionable insights from the IMS Consumer Health Analysis offering.

1. IMS ASIA PACIFIC
IMS Consumer Health Analysis™
Track the latest OTC trends with decision-ready analytics to capitalize on
the growth opportunities in Asia
Are you seizing the Over-the-counter (OTC) opportunities
in your region?
• Worth over US$100 billion the global over-the-counter (OTC)
market continues to grow faster than traditional pharma and is now a key
source of business expansion for most organizations.
• Much of global the OTC growth is driven by developing markets in Latin
America and South East Asia.
• Since 2008, self-diagnosis and self-medicating have created
significant momentum, and driven a surge in worldwide sales of OTC drugs.
• OTC marketing is one of the greatest sources of healthcare information.
• OTC drugs typically carry fewer side effects and warnings than prescription
medicines, tend to be more affordable, and help manage common
symptoms such as pain and cough.
Maximize your • The market in Asia Pacific has grown 21% in 2012 vs a year ago*.
business potential
Without doubt, OTC drugs are in the spotlight. Nowhere is this is more true
than in the Asia-Pacific region, where for the third consecutive year OTC sales
in the region (excluding Japan) have significantly outpaced the global OTC
in the growing market growth.
* Reflects 2012 data
OTC market with IMS Health is introducing IMS Consumer Health (CH) Analysis that will
help clients efficiently track key business metrics at point of sale on a
actionable insights regular basis.
The knowledge that gives you the edge
Based on quality-assured IMS global OTC market intelligence, IMS CH Analysis
-a web-based solution- enables you to understand OTC market dynamics and to
easily identify opportunities for growth and competitive threats.
KEY FEATURES
Coverage IMS CH Analysis has the widest coverage of the most relevant consumer
point of sale of OTC products across:
• Hospitals
• Pharmacies
Geographies CH Analysis will be available in Asia Pacific initially in South Korea,
Thailand, Philippines and Malaysia.
Delivery platform Web-based reports and dashboards
Classification Globally-recognized CH Classification based on positioning and indica-
tion to track immediate competitive set.
Frequency* Monthly* and Quarterly
Granularity of • National View
data & insight • Regional/City*/State* Views
• Sales Channel*
• Galenic / Pack views
• Traffic light benchmarks
Target audience • Business Unit Heads
• Marketing and Brand Managers
• Market Research professionals
• Business Intelligence professionals
• Sales Managers
* Selected countries
IMS ASIA-PACIFIC 10 Hoe Chiang Road, #23-01/02 Keppel Towers, Singapore 089315

2. IMS ASIA PACIFIC
GROW YOUR BUSINESS WITH IMS CONSUMER HEALTH ANALYSIS
Track and monitor in a • Monitors total market, OTC category and brand performance up to pack level
consistent and timely way
• Identifies trends and key competitors at point of sale
• Ensures reliable and consistent delivery to match your business needs
• Decision ready analytics dashboard provides a top-line perspective on a national and regional level
Make better informed decisions • Identify and follow your immediate competitive set using the globally-accepted IMS CH classification
• Discover new growth opportunities using detailed market and geographical views
• Execute and customize action plans based on regional/city*/state* trends and potential
• Understand the interplay between external and internal market forces using market and category
benchmarks
Identify opportunities on time • Track key business metrics with ready-to-use reports at time of subscription
• Anticipate potential challenges and opportunities using detailed trend monitoring reports
* Selected countries
** On demand
Contact your account manager or email us at
info.sg@sg.imshealth.com to learn more about IMS CH Analysis
IMS ASIA-PACIFIC 10 Hoe Chiang Road, #23-01/02 Keppel Towers, Singapore 089315